Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High-risk for Proliferative Vitreoretinopathy (PVR)”

2 trials

Showing 2 of 2 results

Large-scale testing (Phase 3)UnknownNCT05660447
What this trial is testing

A Multi-Center Study on the Use of Rho-Kinase Inhibitor to Reduce or Prevent PVR in RRD Eyes at High Risk for PVR

Who this might be right for
Rhegmatogenous Retinal DetachmentProliferative Vitreoretinopathy
Wills Eye 80
Large-scale testing (Phase 3)Study completedNCT02834559
What this trial is testing

Prophylactic Intravitreal 5-Fluorouracil and Heparin to Prevent PVR in High-risk Patients With Retinal Detachment.

Who this might be right for
Rhegmatogenous Retinal DetachmentHigh-risk for Proliferative Vitreoretinopathy (PVR)
Universitätsklinikum Köln 326

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation